IRON
IRON clinical trials: Disc Medicine, Inc.
Every trial on ClinicalTrials.gov where Disc Medicine, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 11
- Trials linked
- 11
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
IRON on the catalyst calendar · IRON registry changes
- Primary completion Not registeredNo phase registeredNCT07603401Expanded Access Program of Bitopertin For Participants With EPP or XLPDisc Medicine, Inc · Erythropoietic Protoporphyria (EPP)AvailableIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 1NCT07187973A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)Disc Medicine, Inc · Sickle Cell DiseaseRecruitingIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2027Sponsor estimatePhase 2NCT06985147A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)Disc Medicine, Inc · Polycythemia Vera (PV)Active, not recruitingIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2027Sponsor estimatePhase 1/Phase 2NCT05320198Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaDisc Medicine, Inc · Myelofibrosis; AnemiaRecruitingIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 8, 2026ActualPhase 3NCT06910358Study of Bitopertin in Participants With EPP or XLP (APOLLO)Disc Medicine, Inc · Erythropoietic Protoporphyria (EPP)CompletedIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2028Sponsor estimatePhase 2/Phase 3NCT05883748HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in...Disc Medicine, Inc · Erythropoietic ProtoporphyriaEnrolling by invitationIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2026Sponsor estimatePhase 2NCT07368972Study of DISC-0974-201 in Participants With IBD and AnemiaDisc Medicine, Inc · Inflammatory Bowel Disease (IBD)RecruitingIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 9, 2025ActualPhase 1NCT05745883Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and AnemiaDisc Medicine, Inc · Chronic Kidney DiseasesCompletedIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 20, 2024ActualPhase 2NCT05308472Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPPDisc Medicine, Inc · Erythropoietic ProtoporphyriaCompletedIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 9, 2024ActualPhase 1NCT06050915A Study of DISC-3405 in Healthy VolunteersDisc Medicine, Inc · Healthy VolunteerCompletedIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2022ActualPhase 1NCT04999527Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy SubjectsDisc Medicine, Inc · Healthy VolunteerCompletedIRONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 11 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner